Viglita

Vildagliptin
DPP-4 inhibitor (Oral Antidiabetic)

Indication:
ViglitaTM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

Dosage & Administration:
The recommended dose of ViglitaTM is 50 mg or 100 mg daily for monotherapy; 50 mg twice daily (morning and evening) when used in dual combination with Metformin or a Thiazolidinedione; 50 mg once daily in the morning when used in dual combination with a Sulphonylurea.

Preparation:
ViglitaTM 50 Tablet: Each box contains 20 tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides